KENGREXAL Powder for concentrate solution (2020)
Active ingredients: Cangrelor
Product Name and Form
Kengrexal 50 mg powder for concentrate for solution for injection/infusion.
Powder for concentrate for solution for injection/infusion.
White to off-white lyophilised powder.
Qualitative and Quantitative Composition
Each vial contains cangrelor tetrasodium corresponding to 50 mg cangrelor. After reconstitution 1 mL of concentrate contains 10 mg cangrelor. After dilution 1 mL of solution contains 200 micrograms cangrelor.
Excipient with known effect: Each vial contains 52.2 mg sorbitol.
For the full list of excipients, see section 6.1.
Sodium hydroxide (for pH-adjustment)
Pack sizes and Marketing
Powder in 10 mL glass vials (Type 1) closed with a Flurotec coated butyl rubber stopper and sealed with crimped aluminium seal.
Kengrexal is available in packs of 10 vials.
Chiesi Farmaceutici S.p.A., Via Palermo, 26/A, 43122, Parma, Italy
Date of first authorisation: 23 March 2015